Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
NCT03089281
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
699
Enrollment
INDUSTRY
Sponsor class
Conditions
Heart Failure
Interventions
DEVICE:
CRT-D
Sponsor
Boston Scientific Corporation